Mark Johnson

8.4k citations

55 papers · 5.0k indexed · 2 hit papers · h-index 30

Impact in

Orthopedics and Sports Medicine top 1%
- Sports Performance and Training
Clinical Biochemistry top 1%
- Metabolism and Genetic Disorders

Papers in

Clinical Biochemistry 16
- Metabolism and Genetic Disorders 16
Molecular Biology 47
- Mitochondrial Function and Pathology 19
- Muscle Physiology and Disorders 11
- DNA Repair Mechanisms 6
- ATP Synthase and ATPases Research 5
- Cancer therapeutics and mechanisms 4

Co-authors: David R. Appleton Andrew Weightman J. P. Polgár J.B. Harris L. V. B. Nicholson Douglass M. Turnbull Wojciech Niedźwiedź Ketan J. Patel
Journals: Journal of the Neurological Sciences (4 papers)Neuropathology and Applied Neurobiology (3 papers)Scientific Reports (2 papers)Journal of Medical Genetics (2 papers)Annals of Neurology (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Mark Johnson

55 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels 2024 · 51 citations

Peers

Countries citing papers authored by Mark Johnson

Since Specialization

Citations

This map shows the geographic impact of Mark Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Johnson more than expected).

Fields of papers citing papers by Mark Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Johnson. The network helps show where Mark Johnson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Johnson Line = papers co-authored together Mark Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels Cell ·Luis Carlos Tábara, Stephen P. Burr, Ruth M. Bray, Suvagata Roy Chowdhury, Vincent Paupe, Yu Nie, Mark Johnson, Marissa K. Hetrich, Ryan Laughton, Mayuko Segawa, Hanish Anand, Kasparas Petkevicius, Patrick F. Chinnery, Julien Prudent Hit paper breakdown →	2024	51
2	AMPK-dependent phosphorylation of MTFR1L regulates mitochondrial morphology Science Advances ·Lisa Tilokani, Fiona M. Russell, 久保智英, Грудинина Наталья Андреевна, Mayuko Segawa, Vincent Paupe, Anja V. Gruszczyk, Margherita Protasoni, Luis Carlos Tábara, Mark Johnson, Hanish Anand, Michael P. Murphy, D. Grahame Hardie, Franck Polleux, Julien Prudent	2022	40
3	Mutation in the MICOS subunit gene APOO (MIC26) associated with an X-linked recessive mitochondrial myopathy, lactic acidosis, cognitive impairment and autistic features Journal of Medical Genetics ·Cristiane Benincá, D Aledavoud, Michele Brischigliaro, Mark Johnson, 瑞恵鎌田, Yangjung Kim, Alan J. Robinson, T J Metzimekis, John Rey Edralin, AM Kallenbach, Julien Prudent, Enrico Baruffini, Mara Lúcia Schmitz Ferreira Santos, Ricardo Lehtonen Rodrigues de Souza, Erika Fernández‐Vizarra, Alexander J. Whitworth, Massimo Zeviani	2020	37
4	Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by POLR3A mutations Neurology Genetics ·D Aledavoud, 瑞恵鎌田, Mark Johnson, Yangjung Kim, Alan J. Robinson, ISABELLE ORBAN, AM Kallenbach, Ricardo Lehtonen Rodrigues de Souza, Mara Lúcia Schmitz Ferreira Santos, Cristiane Benincá, Massimo Zeviani	2020	4
5	MPV17 Loss Causes Deoxynucleotide Insufficiency and Slow DNA Replication in Mitochondria PLoS Genetics ·Ilaria Dalla Rosa, Yolanda Cámara, Romina Durigon, 徐伟红, Sara Vidoni, C Muralidharan, 希良由利, Mark Johnson, Yarrot Ladislaus Blacy, Liya Wang, David R. Thorburn, Michio Hirano, Joanna Poulton, Robert W. Taylor, Greg Elgar, Ramón Martí, Peter J. Voshol, Ian Holt, Antonella Spinazzola	2016	88
6	Adoptive T-cell therapy improves treatment of canine non–Hodgkin lymphoma post chemotherapy Scientific Reports ·CN Ravishankar, LD MITCHELL, Rizyad Kusuma Wardana, Helen Huls, Mark Johnson, Shana L. Palla, Sourindra N. Maiti, Wencai Ma, R. Eric Davis, Suzanne Craig, Dean A. Lee, Richard E. Champlin, Heather Wilson‐Robles, Laurence J.N. Cooper	2012	55
7	Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM Cellular Signalling ·Ceri M. Wiggins, Mark Johnson, Simon J. Cook	2010	9
8	Studying vertebrate topoisomerase 2 function using a conditional knockdown system in DT40 cells Nucleic Acids Research ·Mark Johnson, I B Hultberg, S.C.J. Bennett, Jennifer M. Spence, Christine J. Farr	2009	23
9	Pharmacokinetics of Acetyl-L-Carnitine Given in Single or Multiple Doses to HIV-1 Infected Patients with Toxic Peripheral Polyneuropathy The Open AIDS Journal ·Christian Herzmann, Stephen P. Reyna, Michael B. Thomas, Patrick Byrne, Mark Johnson, M Youle	2008	2
10	Transcatheter occlusion of baffle leaks following atrial switch procedures for transposition of the great vessels (d‐TGV) Catheterization and Cardiovascular Interventions ·David T. Balzer, Mark Johnson, Angela M. Sharkey, Henry W. Kort	2004	14
11	The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange Carcinogenesis ·James B. Wilson, Mark Johnson, Mohamed Amin, Douglas Richard Anthony, Simon May, Peter E. Bryant, Raymond E. Meyn, Alan D. D’Andrea, Nigel J. Jones	2001	36
12	Accelerated ageing changes in the choroid plexus of a case with multiple mitochondrial DNA deletions Neuropathology and Applied Neurobiology ·David A. Cottrell, Paul G. Ince, T. M. Wardell, Douglass M. Turnbull, Mark Johnson	2001	18
13	Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group Mutagenesis ·Mark Johnson	2000	16
14	Role of Mitochondrial DNA Mutations in Disease and Aging Annals of the New York Academy of Sciences ·David A. Cottrell, Emma L. Blakely, Gillian M. Borthwick, Mark Johnson, Geoffrey A. Taylor, Elizabeth J. Brierley, Paul G. Ince, Douglass M. Turnbull	2000	29
15	The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants Mutation Research/DNA Repair ·Mark Johnson, Nigel J. Jones	1999	21
16	Epidemiology of cerebral palsy in England and Scotland, 1984–9 Archives of Disease in Childhood Fetal & Neonatal ·P O Pharoah, T Cooke, Mark Johnson, Rosemary King, Lesley Mutch	1998	152
17	A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis Annals of Neurology ·Patrick F. Chinnery, Mark Johnson, Robert W. Taylor, Robert N. Lightowlers, Douglass M. Turnbull	1997	36
18	Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy Neuromuscular Disorders ·Kate Bushby, Judith A. Goodship, L. V. B. Nicholson, Mark Johnson, S. S. Ford, D. Gardner‐Medwin	1993	50
19	Absence of immunoreactive enzyme protewin in short‐chain acylcoenzyme a dehydrogenase deficiency Annals of Neurology ·UNICEF, Vimlesh. Rajbansi, Mark Johnson, Laurence A. Bindoff, Douglass M. Turnbull	1990	5
20	Improved diagnosis of Becker muscular dystrophy by dystrophin testing Neurology ·Eric P. Hoffman, Louis M. Kunkel, C. Angelini, Angus Clarke, Mark Johnson, J.B. Harris	1989	242

About Mark Johnson

Mark Johnson is a scholar working on Clinical Biochemistry, Molecular Biology, Aging, Cellular and Molecular Neuroscience and Oncology, having authored 55 papers that have together received 5.0k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (19 papers), Metabolism and Genetic Disorders (16 papers), Muscle Physiology and Disorders (11 papers), DNA Repair Mechanisms (6 papers), Genetic Neurodegenerative Diseases (6 papers), ATP Synthase and ATPases Research (5 papers), Adipose Tissue and Metabolism (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Orthopedics and Sports Medicine (718 citations), Clinical Biochemistry (351 citations), Molecular Biology (2.7k citations), Complementary and alternative medicine (248 citations) and Biomedical Engineering (1.3k citations). Mark Johnson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include David R. Appleton, Andrew Weightman, J. P. Polgár, J.B. Harris, L. V. B. Nicholson, Douglass M. Turnbull, Wojciech Niedźwiedź, Ketan J. Patel, Georgina Mosedale and Paul Pace. Their work appears in journals such as Journal of the Neurological Sciences, Neuropathology and Applied Neurobiology, Scientific Reports, Journal of Medical Genetics and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact